by Michael Mickel md; Rainer Kunstfeld mD; and Richard Crevenna, MD Drs. Mickel and Crevenna are with the Department of Physical Medicine, Rehabilitation, and Occupational Medicine at the Medical University
by Mohamed H. Khater, MD; Mohamed Soliman, MD; Amin Amer, MD; Fatehy Khater, MD; and Manal R. Abd elhaleem, mD Dr. M. Khater is Assistant Professor of Dermatology and Venereology,
by Mario Tagliagambe, MD; Tuan A. Elstrom, BS; and Daniel B. Ward, Jr, MD, FAAD Dr. Tagliagambe is a primary care physician at Adirondack Health in Saranac Lake, New York.
by Matthew B. Zarraga, DO; Nicole Swenson, DO; and Brad Glick, DO, MPH, FAOCD Dr. Zarraga is the chief dermatology resident at Wellington Regional Medical Center in Wellington, Florida; Dr. Swenson
by Philip R. Cohen, MD Dr. Cohen is from the Department of Dermatology at the University of California San Diego, La Jolla, California. Funding: No funding was provided for this
by Laura Paul Fite, MD, and Philip R. Cohen, MD Dr. Fite is with Shenandoah Dermatology in Staunton, Virginia. Dr. Cohen is with the Department of Dermatology at University of
by Natalie Z. Sun, MD; Teresa Ro, BS; Puneet Jolly, MD, PhD; Christopher J. Sayed, MD All authors are with the University of North Carolina at Chapel Hill, Dermatology, in
by Philip R. Cohen, MD, and S. Brian Jiang, MD Drs. Cohen and Jiang are with the Department of Dermatology at the University of California San Diego, in La Jolla,
by Ryan R. Riahi, MD, and Philip R. Cohen, MD Dr. Riahi is with DermSurgery Associates, Houston, Texas; and Dr. Cohen is with the Department of Dermatology, University of California
Philip R. Cohen, MD Department of Dermatology, University of California San Diego, La Jolla, California Disclosure: The author reports no relevant conflicts of interest. Abstract Red dot basal cell carcinoma,
aXinyi Yang, BMed/MD; bMatthew S. Dinehart, BA, MEd aThe Royal Prince Alfred Hospital, Camperdown, NSW, Australia aUniversity of Arkansas for Medical Sciences, Little Rock, Arkansas Disclosure: The authors report no
aDavid B. Harker, MD; bJake E. Turrentine, MD; aSeemal R. Desai, MD aThe University of Texas Southwestern Medical Center, Dallas, Texas bMedical College of Georgia at Augusta University, Augusta, Georgia
aJoseph R. Kallini, MD; bAmor Khachemoune, MD, FAAD, FACMS aDetroit Medical Center / Wayne State University, Detroit, Michigan; bVeterans Affairs Medical Center, Brooklyn, New York Disclosure: The authors report no
aAlyson Snyder, DO; bRachel A. Schiechert, MD; cMartin N. Zaiac, MD aTraditional Rotating Intern, Broward Health Medical Center, Fort Lauderdale, Florida bHollywood Dermatology & Cosmetic Specialists, Hollywood, Florida cChairman, Department
aMarisa Wolff, DO; aChristopher Mancuso, DO; bKaran Lal, BS; cDamian DiCostanzo, MD; a,dCharles Gropper, MD aSt. Barnabas Hospital Dermatology Residency, Bronx, New York bNew York College of Osteopathic Medicine-NYIT, Old
aMarisa Wolff, DO; bNina Sabzevari, MSIV; cCharles Gropper, MD; dCindy Hoffman, DO aChief Resident, New York College of Osteopathic Medicine of New York Institute of Technology, Department of Dermatology, St.
a–cOrit Markowitz, MD; a–cMichelle Schwartz, BA aSUNY Downstate Medical Center, Brooklyn, New York; bNew York Harbor Healthcare System, Brooklyn, New York; cMount Sinai Medical Center, New York, New York Disclosure:
aEric Ehrsam, MD; bJoseph R. Kallini, MD; aDamien Lebas, MD; cAmor Khachemoune, MD; aPhilippe Modiano, MD; dHervé Cotten, MD aService de dermatologie, université catholique de Lille, hôpital Saint-Vincent-de-Paul, Lille, France
Ani Tajirian, MD; Michelle Tsui, BA Webster Management, Inc. (Private Practice), Oakland, California Disclosure: The authors report no relevant conflicts of interest Abstract Objective: Following Mohs surgery, medium-to-large defects on
aDavid N. Lortscher, MD; aPhilip R. Cohen, MD; bCarolyn A. Bangert, MD; aTaraneh Paravar, MD aThe Division of Dermatology, University of California San Diego, San Diego, California; bThe Department of